Effects of insulin therapy optimization with sensor augmented pumps on glycemic control and body composition in people with cystic fibrosis-related diabetes
ObjectiveCystic fibrosis (CF)-related diabetes (CFRD) resulting from partial-to-complete insulin deficiency occurs in 40-50% of adults with CF. In people with CFRD, poor glycemic control leads to a catabolic state that may aggravate CF-induced nutritional impairment and loss of muscle mass. Sensor a...
Main Authors: | V. Grancini, G. Alicandro, L. L. Porcaro, L. Zazzeron, A. Gramegna, L. C. Morlacchi, V. Rossetti, A. Gaglio, V. Resi, V. Daccò, F. Blasi, E. Orsi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-08-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2023.1228153/full |
Similar Items
-
Quality of dietary macronutrients is associated with glycemic outcomes in adults with cystic fibrosis
by: Tanicia C. Daley, et al.
Published: (2023-09-01) -
Insulin therapy in patients with cystic fibrosis in the pre-diabetes stage: a systematic review
by: Mariana Zorrón Mei Hsia Pu, et al. -
Rapid-Acting Insulin Used to Treat a Case of Early Cystic Fibrosis–Related Diabetes Complicated by Post Prandial Hypoglycemia
by: Tamar Wolinsky, MD, et al.
Published: (2023-09-01) -
Combined CFTR modulator therapies are linked with anabolic benefits and insulin-sparing in cystic fibrosis-related diabetes
by: Fabian Lurquin, et al.
Published: (2023-09-01) -
The effect of cystic fibrosis transmembrane conductance regulator modulators on impaired glucose tolerance and cystic fibrosis related diabetes
by: Sana Hasan, et al.
Published: (2022-09-01)